-transparent.png){kind=logo}
The article discusses 6-year experience in the treatment and prevention of esophageal hemorrhage by endoscopic sclerotherapy using 96% and 70% ethanol as the sclerosant. There were 99 patients under observation whose ages ranged from 27 to 70 years, 74 were admitted to the clinic with profuse hemorrhage. Sclerotherapy arrested the bleeding in 65 (90%) patients. Seven patients died from persisting bleeding, 5 from increasing hepatic insufficiency, and one patient from perforation of the esophagus and purulent mediastinitis. After discharge from the clinic 54 patients were kept under observation for periods of 6 to 20 months; 16 episodes of bleeding occurred in 13 of them. Repeated sclerotherapy proved effective in 10 patients, 3 patients died from continuing bleeding and hepatic insufficiency.
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
November 1974,
Klinicheskaia khirurgiia,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
November 1985,
Klinicheskaia meditsina,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
January 2023,
Arkhiv patologii,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
September 1991,
Khirurgiia,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
March 1984,
Khirurgiia,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
July 1983,
Khirurgiia,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
January 2006,
Khirurgiia,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
August 1981,
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
January 1986,
Sovetskaia meditsina,
A P Dotsenko, and
D V Gerasimov, and
V V Grubnik
March 1976,
Meditsinskaia sestra,
